Renub

    Australia Diabetes Market, Size, Forecast 2023-2028, By SMBG Device, Continuous Glucose Monitoring (CGM), Insulin Pen, Insulin Pump, and Company Analysis

    Excel: 8 Hours
    PDF: 24 Hours
    Mar 2023
    Pages: 190

    Australia Diabetes Market Outlook

    Australia Diabetes Market will reach US$ 5.96 Billion in 2028 and it will expand at a CAGR of 7.14% from 2022 to 2028, according to Renub Research. In recent years, Australia diabetes has been on the rise. The diabetes burden in Australia shows no sign of slowing, and its health and economic impact continue to be felt by people with diabetes. Almost 1.9 million Australians have diabetes and it is the seventh most common cause of death by disease. Australia is home to an aging population and the Australian Government, like other governments worldwide, faces the challenge of dealing with the issue of rising healthcare costs. Obesity is an increasingly serious issue for Australia. The number of people with type 2 diabetes is growing, most likely the result of rising overweight and obesity rates, lifestyle and dietary changes, and an ageing population. Australia Diabetes Market was US$ 3.94 Billion in 2022.

    australia-diabetes-market


    Type 2 Diabetes is Increasing Year on Year

    The number of people living with diabetes in Australia increased almost 2.8-fold between 2000 and 2020. Currently, 134 thousand Australians are living with type 1 diabetes. Type 1 diabetes is usually confirmed with an extra blood test to check autoantibodies. However, type 2 diabetes is increasing at the fastest rate in Australia. Type 2 diabetes is one of the significant consequences of the modern lifestyle. In addition, the number of people with silent, undiagnosed type 2 diabetes may be damaging their bodies. An estimated 2 million Australians are at high risk of developing type 2 diabetes and are already showing early signs of the condition.


    Growing Number of Diabetes cases in Australia will create demand for Insulin Pens

    The Australian diabetes market is classified into Self-Monitoring Blood Glucose Devices, Continuous Glucose Monitoring (CGM) Devices, Insulin pens, and Insulin Pumps. The growing adoption of insulin-delivery devices and the rising prevalence of diabetes are driving market growth. Therefore, leading Australian manufacturers are focusing on technological innovations and developing advanced products to gain a substantial market share. The rapidly increasing incidence and prevalence of diabetic patients and healthcare expenditure in Australia are indications of the increasing usage of diabetic care products.

    After Insulin Pens, CGMs accounted for the largest share of the Australian diabetes market. Increasing adoption of CGM systems, development of advanced CGM systems, favorable government policies, and promotion of the adoption of CGM devices are the key factors contributing to this segment capturing maximum share and highest growth.


    Australian Government has developed a National Diabetes Strategy

    The government plays a significant role in assuring that people with diabetes can access affordable, high-quality equipment and services to help in self-management and care. The National Diabetes Services Plan, the Prescription Benefits Scheme, the Insulin Pump Program, and Medicare are all initiatives the Australian government administers to assist people with diabetes.

    More than 3.1 million Australians will live with diabetes by 2050; around one in every 12 Australians, According to Diabetes Australia administers the National Diabetes Services Scheme (NDSS). Direct healthcare, hospital costs, and medicines have exploded in the past two decades, while hospitalizations have increased since 2004. The diabetes epidemic is one of the most significant health challenges Australia has ever faced, and it calls for unified and sustained action.


    Key Players Analysis

    The major players are B. Braun Melsungen AG, Eli Lilly and Company, Terumo Corporation, Becton, Dickinson (BD), Novo Nardisk, Ypsomed AG, Medtronic, Insulet Corporations, Abbott Laboratories, DarioHealth Crop, Dexcom, Inc, Roche Diagnostic, Tandem Diabetes Care.

    • In January 2021, the National Diabetes Services Scheme (NDSS) Australia approved using the Dexcom G6 CGM device through the NDSS Subsidy Initiative if diabetes patients use a Tandem t: slim X2 insulin pump and meet the NDSS criteria.
    • In Feb 2020, the Australian government initiated USD 300 Million CGM (Continuous Glucose Monitoring) (FreeStyleLibre flash glucose monitoring system) free access to eligible type-1 diabetes patients.


    Renub Research report titled “AustraliaDiabetes Market & Forecast, By Continuous Glucose Monitoring (CGM Market by Components, Glucose Sensor, Transmitter, CGM User, Reimbursement), Self-Monitoring Blood Glucose Device Analysis (SMBG Market by, Test Strips, Lancet, Meter, Blood Glucose Device Users & Reimbursement) Insulin Pen Analysis – (User, Types – Disposable, Reusable and Smart Insulin Pen, Insulin Pen Needle Market, Reimbursement Policies), Insulin Pump Analysis- (Users, Market & Differentiation Points of Insulin Pump Products, Training Model for Patients & HCP, Reimbursement Policies) Companies (B. Braun Melsungen AG, Eli Lilly and Company, Terumo Corporation, Becton, Dickinson (BD), Novo Nardisk, Ypsomed AG, Medtronic, Insulet Cororation, Abbott Laboratories, DarioHealth Crop, Dexcom, Inc, Roche Diagnostic, Tandem Diabetes Care)” provides a complete analysis of Australia Insulin Delivery Devices Market.

    australia-diabetes-market-share


    Segments Market based on Devices

    1.    Continuous Glucose Monitoring (CGM)
    2.    Self Monitoring Blood Glucose (SMBG)
    3.    Insulin Pen
    4.    Insulin Pump


    Australia Diabetes Sub-Segment Analysis

    1. Continuous Glucose Monitoring (CGM)

    1.    Glucose Sensor Market & Forecast
    2.    CGM Transmitter Market & Forecast
    3.    CGM User
    4.    CGM Reimbursement


    2. SMBG

    1.    Test Strips Market and Forecast
    2.    Lancet Market and Forecast
    3.    Meter Market and Forecast
    4.    Blood Glucose (SMBG) Users
    5.    Blood Glucose Devices Reimbursement


    3. Insulin Pen Market

    1.    Disposable Insulin Pen
    2.    Reusable Insulin Pen
    3.    Smart Insulin Pen
    4.    Insulin Pen Needle Market
    5.    Insulin Pen Users
    6.    Reimbursement Policies


    4. Insulin Pump Market

    1.    Insulin Pump Market
    2.    Insulin Pump Users
    3.    Insulin Pump Products
    4.    Reimbursement Policies


    All the 13 Companies Studied in the Report have been Studied from 3 Points

    •    Company Overview
    •    Recent Developments
    •    Financial Insight


    Company Analysis

    1.    B. Braun Melsungen AG
    2.    Eli Lilly and Company
    3.    Terumo Corporation
    4.    Becton, Dickinson (BD)
    5.    Novo Nardisk
    6.    Ypsomed AG
    7.    Medtronic
    8.    InsuletCororation
    9.    Abbott Laboratories
    10.    DarioHealth Crop
    11.    Dexcom, Inc
    12.    Roche Diagnostic
    13.    Tandem Diabetes Care


    Report Details:

    Report Features Details
    Base Year 2022
    Historical Period 2017 - 2022
    Forecast Period 2023 - 2028
    Market US$ Billion
    Segment Covered CGM, SMBG, Insulin Pump, and Insulin Pen
    Companies Covered B. Braun Melsungen AG, Eli Lilly and Company, Terumo Corporation, Becton, Dickinson (BD), Novo Nardisk, Ypsomed AG, Medtronic, Insulet Cororation, Abbott Laboratories, DarioHealth Crop, Dexcom, Inc, Roche Diagnostic, and Tandem Diabetes Care
    Customization Scope 20% Free Customization
    Post-Sale Analyst Support 1 Year (52 Weeks)
    Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request)


    Key Benefits of the Report

    • This report provides current market estimates and forecasts for Australia Diabetic Market.
    • Detailed analysis of the key market segments such as source, geography and applications; provides a comprehensive understanding of the market.
    • Detailed analysis of Australia SMBG Market.
    • Detailed analysis of Australia CGM Market.
    • Detailed analysis of Australia Insulin Pump Market.
    • Detailed analysis of Australia Insulin Pen Market.
    • Australia Diabetic Market – Growth Drivers and Challenges.
    • Key sustainability strategies adopted by market players.

    1.    Introduction

    2.    Research & Methodology

    3.    Executive Summary

    4.    Market Dynamics

    4.1    Growth Drivers
    4.2    Challenges


    5.    Australia Diabetes Market

    6.    Australia Diabetes Population

    6.1    Type 1 Diabetes
    6.2    Type 2 Diabetes


    7.    Market Share – Australia Diabetes Analysis

    7.1    By Types


    8.    Continuous Glucose Monitoring Market (CGM) – Market & Users

    8.1    CGM Market by Components

    8.1.1    Glucose Sensor Market
    8.1.2    CGM Transmitter Market

    8.2    CGM User
    8.3    Reimbursement Policies of CGM Devices in Australia


    9.    Blood Glucose Device (SMBG) – Australia Market & Users

    9.1    Market

    9.1.1    Type 1 Diabetes Market
    9.1.2     Type 2 Diabetes Market

    9.2    Test Strips Market

    9.2.1    Type 1 Diabetes
    9.2.2    Type 2 Diabetes

    9.3    Lancet Market

    9.3.1    Type 1 Diabetes
    9.3.2    Type 2 Diabetes

    9.4    Meter Market and Forecast

    9.4.1    Type 1 Diabetes
    9.4.2    Type 2 Diabetes

    9.5    Blood Glucose (SMBG) Users

    9.5.1    Type 1 Diabetes
    9.5.2    Type 2 Diabetes

    9.6    Reimbursement Policies of Blood Glucose Devices in Australia


    10.    Insulin Pen – Australia Market & User Analysis

    10.1    Insulin Pen Market

    10.1.1    Disposable Insulin Pen Market
    10.1.2    Reusable Insulin Pen Market
    10.1.3    Smart Insulin Pen Market

    10.2    Insulin Pen User

    10.2.1    Disposable Insulin Pen User
    10.2.2    Reusable Insulin Pen User
    10.2.3    Smart Insulin Pen User

    10.3    Insulin Pen Needle Market
    10.4    Reimbursement Policies of Insulin Pen in Australia


    11.    Insulin Pump – Australia Market & Users

    11.1    Insulin Pump Market

    11.1.1    Type 1 Diabetes Market
    11.1.2    Type 2 Diabetes Market

    11.2    Insulin Pump User

    11.2.1    Type 1 Insulin Pump User
    11.2.2    Type 2 Insulin Pump User

    11.3    Differentiation Points of Insulin Pump Products in Australia

    11.3.1    Animas Vibe
    11.3.2    Medtronic 530G with Enlite
    11.3.3    Insulet OmniPod
    11.3.4    Tandem t: slim
    11.3.5    Roche Accu-Chek Combo

    11.4    Training Model for Patients & HCP – of Medtronic, Animas, Insulet Corp & Tandem Diabetes Care

    11.4.1    Medtronic

    11.5    Insulet Corporation

    11.5.1    Training Structure for New Patients - Insulet Corporation

    11.6    Animas Corporation

    11.6.1    Training Modules for New Patients
    11.6.2    Training Modules for HCP (Health Care Professional)

    11.7    Tandem Diabetes Care
    11.8    Reimbursement Policies Insulin Pump 


    12.    Insulin Pen – Company Analysis

    12.1    B. Braun Melsungen AG

    12.1.1    Overview
    12.1.2    Recent Developments
    12.1.3    Revenue

    12.2    Eli Lilly

    12.2.1    Overview
    12.2.2    Recent Developments
    12.2.3    Revenue

    12.3    Terumo Corporation

    12.3.1    Overview
    12.3.2    Recent Developments
    12.3.3    Revenue

    12.4    BD

    12.4.1    Overview
    12.4.2    Recent Developments
    12.4.3    Revenue

    12.5    Novo Nordisk A/S

    12.5.1    Overview
    12.5.2    Recent Developments
    12.5.3    Revenue

    12.6    Ypsomed AG

    12.6.1    Overview
    12.6.2    Recent Developments
    12.6.3    Revenue


    13.    Insulin Pump – Company Analysis

    13.1    Medtronic

    13.1.1    Overview
    13.1.2    Recent Developments
    13.1.3    Revenue

    13.2    Insulet Corporation

    13.2.1    Overview
    13.2.2    Recent Developments
    13.2.3    Revenue


    14.    SMBG – Company Analysis

    14.1    LifeScan Inc.

    14.1.1    Overview
    14.1.2    Recent Developments
    14.1.3    Revenue

    14.2    Abbott Laboratories

    14.2.1    Overview
    14.2.2    Recent Developments
    14.2.3    Revenue


    15.    CGM – Company Analysis

    15.1    Dexcom Inc

    15.1.1    Overview
    15.1.2    Recent Developments
    15.1.3    Revenue

    15.2    Roche

    15.2.1    Overview
    15.2.2    Recent Developments
    15.2.3    Revenue

    15.3    Tandem Diabetes Care

    15.3.1    Overview
    15.3.2    Recent Developments
    15.3.3    Revenue


    List of Figures:

    Figure-01:    Australia – Diabetes Market (Billion US$), 2017 – 2022
    Figure-02:    Australia – Forecast for Diabetes Market (Billion US$), 2023 – 2028
    Figure-03:    Australia – Type 1 Diabetes Population (Thousand), 2017 – 2022
    Figure-04:    Australia – Forecast for Type 1 Diabetes Population (Thousand), 2023 – 2028
    Figure-05:    Australia – Type 2 Diabetes Population (Thousand), 2017 – 2022
    Figure-06:    Australia – Forecast for Type 2 Diabetes Population (Thousand), 2023 – 2028
    Figure-07:    Australia – Glucose Sensor Market (Million US$), 2017 – 2023
    Figure-08:    Australia – Forecast for Glucose Sensor Market (Million US$), 2023 – 2028
    Figure-09:    Australia – CGM Transmitter Market (Million US$), 2017 – 2023
    Figure-10:    Australia – Forecast for CGM Transmitter Market (Million US$), 2023 – 2028
    Figure-11:    Australia – CGM User (Thousand), 2017 – 2023
    Figure-12:    Australia – Forecast for CGM User (Thousand), 2023 – 2028
    Figure-13:    Australia – Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2023 – 2028
    Figure-14:    Australia – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Diabetes Market (Million US$), 2017 – 2023
    Figure-15:    Australia – Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2023 – 2028
    Figure-16:    Australia – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Diabetes Market (Million US$), 2017 – 2023
    Figure-17:    Australia – Test Strips Type 1 Diabetes Market (Million US$), 2023 – 2028
    Figure-18:    Australia – Forecast for Test Strips Type 1 Diabetes Market (Million US$), 2017 – 2023
    Figure-19:    Australia – Test Strips Type 2 Diabetes Market (Million US$), 2023 – 2028
    Figure-20:    Australia – Forecast for Test Strips Type 2 Diabetes Market (Million US$), 2017 – 2023
    Figure-21:    Australia – Lancet Type 1 Diabetes Market (Million US$), 2023 – 2028
    Figure-22:    Australia – Forecast for Lancet Type 1 Diabetes Market (Million US$), 2017 – 2023
    Figure-23:    Australia – Lancet Type 2 Diabetes Market (Million US$), 2023 – 2028
    Figure-24:    Australia – Forecast for Lancet Type 2 Diabetes Market (Million US$), 2017 – 2023
    Figure-25:    Australia – Meter Type 1 Diabetes Market (Million US$), 2023 – 2028
    Figure-26:    Australia – Forecast for Meter Type 1 Diabetes Market (Million US$), 2017 – 2023
    Figure-27:    Australia – Meter Type 2 Diabetes Market (Million US$), 2023 – 2028
    Figure-28:    Australia – Forecast for Meter Type 2 Diabetes Market (Million US$), 2017 – 2023
    Figure-29:    Australia – Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2017 – 2022
    Figure-30:    Australia – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 1 Users (Thousand), 2023 – 2028
    Figure-31:    Australia – Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2017 – 2022
    Figure-32:    Australia – Forecast for Self-Monitoring of Blood Glucose (SMBG) Type 2 Users (Thousand), 2023 – 2028
    Figure-33:    Australia – Disposable Insulin Pen Market (Million US$), 2017 – 2023
    Figure-34:    Australia – Forecast for Disposable Insulin Pen Market (Million US$), 2023 – 2028
    Figure-35:    Australia – Reusable Insulin Pen Market (Million US$), 2017 – 2023
    Figure-36:    Australia – Forecast for Reusable Insulin Pen Market (Million US$), 2023 – 2028
    Figure-37:    Australia – Smart Insulin Pen Market (Million US$), 2017 – 2023
    Figure-38:    Australia – Forecast for Smart Insulin Pen Market (Million US$), 2023 – 2028
    Figure-39:    Australia – Disposable Insulin Pen User (Thousand), 2017 – 2022
    Figure-40:    Australia – Forecast for Disposable Insulin Pen User (Thousand), 2023 – 2028
    Figure-41:    Australia – Reusable Insulin Pen User (Thousand), 2017 – 2022
    Figure-42:    Australia – Forecast for Reusable Insulin Pen User (Thousand), 2023 – 2028
    Figure-43:    Australia – Smart Insulin Pen User (Thousand), 2017 – 2022
    Figure-44:    Australia – Forecast for Smart Insulin Pen User (Thousand), 2023 – 2028
    Figure-45:    Australia – Insulin Pen Needle Market (Million US$), 2017 – 2023
    Figure-46:    Australia – Forecast for Pen Needle Market (Million US$), 2023 – 2028
    Figure-47:    Australia – Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2017 – 2023
    Figure-48:    Australia – Forecast for Insulin Pump Market for Type 1 Diabetes Market (Million US$), 2023 – 2028
    Figure-49:    Australia – Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2017 – 2023
    Figure-50:    Australia – Forecast for Insulin Pump Market for Type 2 Diabetes Market (Million US$), 2023 – 2028
    Figure-51:    Australia – Insulin Pump Type 1 Users (Thousand), 2017 – 2022
    Figure-52:    Australia – Forecast for Insulin Pump Type 1 Users (Thousand), 2023 – 2028
    Figure-53:    Australia – Insulin Pump Type 2 Users (Thousand), 2017 – 2022
    Figure-54:    Australia – Forecast for Insulin Pump Type 2 Users (Thousand), 2023 – 2028
    Figure-55:    B. Braun Melsungen AG – Global Revenue (Billion US$), 2017 – 2022
    Figure-56:    B. Braun Melsungen AG – Forecast for Global Revenue (Billion US$), 2023 – 2028
    Figure-57:    Eli Lilly – Global Revenue (Million US$), 2017 – 2022
    Figure-58:    Eli Lilly – Forecast for Global Revenue (Million US$), 2023 – 2028
    Figure-59:    Terumo Corporation – Global Revenue (Billion US$), 2017 – 2022
    Figure-60:    Terumo Corporation – Forecast for Global Revenue (Billion US$), 2023 – 2028
    Figure-61:    BD – Global Revenue (Billion US$), 2017 – 2022
    Figure-62:    BD – Forecast for Global Revenue (Billion US$), 2023 – 2028
    Figure-63:    Novo Nordisk A/S – Global Revenue (Million US$), 2017 – 2022
    Figure-64:    Novo Nordisk A/S – Forecast for Global Revenue (Million US$), 2023 – 2028
    Figure-65:    Ypsomed AG – Global Revenue (Million US$), 2017 – 2022
    Figure-66:    Ypsomed AG – Forecast for Global Revenue (Million US$), 2023 – 2028
    Figure-67:    Medtronic – Global Revenue (Billion US$), 2017 – 2022
    Figure-68:    Medtronic – Forecast for Global Revenue (Billion US$), 2023 – 2028
    Figure-69:    Insulet Corporation – Global Revenue (Million US$), 2017 – 2022
    Figure-70:    Insulet Corporation – Forecast for Global Revenue (Million US$), 2023 – 2028
    Figure-71:    DarioHealth Corp – Global Revenue (Million US$), 2017 – 2022
    Figure-72:    DarioHealth Corp – Forecast for Global Revenue (Million US$), 2023 – 2028
    Figure-73:    Abbott Laboratories – Global Revenue (Billion US$), 2017 – 2022
    Figure-74:    Abbott Laboratories – Forecast for Global Revenue (Billion US$), 2023 – 2028
    Figure-75:    Dexcom Inc – Global Revenue (Billion US$), 2017 – 2022
    Figure-76:    Dexcom Inc – Forecast for Global Revenue (Billion US$), 2023 – 2028
    Figure-77:    Roche – Global Revenue (Billion US$), 2017 – 2022
    Figure-78:    Roche – Forecast for Global Revenue (Billion US$), 2023 – 2028
    Figure-79:    Tandem Diabetes Care – Global Revenue (Million US$), 2017 – 2022
    Figure-80:    Tandem Diabetes Care – Forecast for Global Revenue (Million US$), 2023 – 2028


    List of Tables:

    Table-01:    Australia – Diabetes Market Share by Type (Percent), 2017 – 2022
    Table-02:    Australia – Forecast for Diabetes Market Share by Type (Percent), 2023 – 2028

    • Description
      Price
    • Chapter 1, 4 & 5     Pages : 7
      $300
    • Chapter 6     Pages : 4
      $300
    • Chapter 8     Pages : 7
      $300
    • Chapter 9     Pages : 21
      $800
    • Chapter 10     Pages : 15
      $600
    • Chapter 11.1     Pages : 4
      $300
    • Chapter 11.2     Pages : 4
      $300
    • Chapter 11.3     Pages : 5
      $300
    • Chapter 11.4, 11.5, 11.6, 11.7 & 11.8     Pages : 7
      $300
    • Chapter 12.1     Pages : 5
      $150
    • Chapter 12.2     Pages : 5
      $150
    • Chapter 12.3     Pages : 5
      $150
    • Chapter 12.4     Pages : 5
      $150
    • Chapter 12.5     Pages : 5
      $150
    • Chapter 12.6     Pages : 5
      $150
    • Chapter 13.1     Pages : 5
      $150
    • Chapter 13.2     Pages : 5
      $150
    • Chapter 14.1     Pages : 5
      $150
    • Chapter 14.2     Pages : 5
      $150
    • Chapter 15.1     Pages : 5
      $150
    • Chapter 15.2     Pages : 5
      $150
    • Chapter 15.3     Pages : 5
      $150

    Related Reports